The Flow and Image Cytometry Resource provides advanced flow cytometric and morphology service at the light and electron microscope (EM) levels of resolution utilizing state-of-the-art technology and an extensive computer network that has been assembled into a user-friendly environment. The Resource is supervised by Paul K. Wallace, PhD, and Hans Minderman, PhD, and is staffed by five technical personnel. The goal is to provide (i) multiparameter flow cytometry, encompassing analytical, sorting and Luminex services, (ii) morphological services at the light and EM levels of resolution, and (iii) instruction and technical support as required by investigators. As a focal point for many interdisciplinary activities throughout RPCI, the Resource supports both basic research and clinical protocol services. The Resource has an extensive immunophenotyping service and is the core flow cytometric laboratory for many NIH-initiated national clinical trials. The Flow Cytometry Component of the Resource offers both clinical and basic research support services, which universally maintain a quality assurance program using guidelines from state and national accrediting agencies. The Imaging Component enables qualitative and quantitative image analysis on the tissue, cellular and subcellular levels, time-kinetic multicolor image analysis and quantitative multispectral image analysis. The Educational Program Component provides didactic lectures and hands-on experience with (i) isolation, preparation, and staining of all types of human and animal cells, (ii) instrument setup and acquisition, and (iii) data analysis, The Resource has complete general biology, tissue culture, optics and electronics, and computer laboratories, as well as a fabrication shop. The Resource's strategic plan emphasizes the provision of stateof- the-art technology and expertise in all facets of flow and image cytometry, and supporting the needs of CCSG Program members to enhance peer-reviewed funding and publications. During the reporting period (4/1/06 to 3/31/07), the Resource contributed to the research of 67 investigators from all six CCSG Programs, with 85% of Resource utilization by CCSG Program members with peer-reviewed funding. $110,245 in CCSG support is requested, representing 8% of the total operating budget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-35
Application #
8296643
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2011-05-01
Budget End
2012-04-30
Support Year
35
Fiscal Year
2011
Total Cost
$251,310
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Ling, Xiang; Wu, Wenjie; Fan, Chuandong et al. (2018) An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. J Exp Clin Cancer Res 37:240
Chung, Sejin; Vail, Paris J; Witkiewicz, Agnieszka K et al. (2018) Coordinately targeting cell cycle checkpoint functions in integrated models of pancreatic cancer. Clin Cancer Res :
Eng, Diana G; Kaverina, Natalya V; Schneider, Remington R S et al. (2018) Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracing. Kidney Int 93:1240-1246
Hsu, Alice H; Lum, Michelle A; Shim, Kang-Sup et al. (2018) Crosstalk between PKC? and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. Cell Rep 24:655-669
Sandlesh, Poorva; Juang, Thierry; Safina, Alfiya et al. (2018) Uncovering the fine print of the CreERT2-LoxP system while generating a conditional knockout mouse model of Ssrp1 gene. PLoS One 13:e0199785
Mohammadpour, Hemn; O'Neil, Rachel; Qiu, Jingxin et al. (2018) Blockade of Host ?2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs. J Immunol 200:2479-2488
Damayanti, Nur P; Budka, Justin A; Khella, Heba W Z et al. (2018) Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma. Clin Cancer Res 24:5977-5989
Mayor, Paul; Starbuck, Kristen; Zsiros, Emese (2018) Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies. Gynecol Oncol 150:361-369
Zhang, Dingxiao; Zhao, Shuhong; Li, Xinyun et al. (2018) Prostate Luminal Progenitor Cells in Development and Cancer. Trends Cancer 4:769-783
Hong, Chi-Chen; Sucheston-Campbell, Lara E; Liu, Song et al. (2018) Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiol Biomarkers Prev 27:321-330

Showing the most recent 10 out of 1555 publications